These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 24709521)
21. Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silico modeling, in vitro and in vivo evaluation. Pathak P; Dhawan V; Magarkar A; Danne R; Govindarajan S; Ghosh S; Steiniger F; Chaudhari P; Gopal V; Bunker A; Róg T; Fahr A; Nagarsenker M Int J Pharm; 2016 Jul; 509(1-2):149-158. PubMed ID: 27231122 [TBL] [Abstract][Full Text] [Related]
22. Novel Galactosylated Poly(ethylene glycol)-Cholesterol for Liposomes as a Drug Carrier for Hepatocyte-Targeting. Zhang H; Xiao Y; Cui S; Zhou Y; Zeng K; Yan M; Zhao C J Nanosci Nanotechnol; 2015 Jun; 15(6):4058-69. PubMed ID: 26369013 [TBL] [Abstract][Full Text] [Related]
23. Synergistic enhancement of anticancer therapeutic efficacy of HPMA copolymer doxorubicin conjugates via combination of ligand modification and stimuli-response srategies. Li L; Zhou M; Huang Y Int J Pharm; 2018 Jan; 536(1):450-458. PubMed ID: 29237570 [TBL] [Abstract][Full Text] [Related]
24. Effects of surface displayed targeting ligand GE11 on liposome distribution and extravasation in tumor. Tang H; Chen X; Rui M; Sun W; Chen J; Peng J; Xu Y Mol Pharm; 2014 Oct; 11(10):3242-50. PubMed ID: 25181533 [TBL] [Abstract][Full Text] [Related]
25. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin. Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461 [TBL] [Abstract][Full Text] [Related]
26. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model. Moosavian SA; Abnous K; Badiee A; Jaafari MR Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819 [TBL] [Abstract][Full Text] [Related]
27. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics. Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092 [TBL] [Abstract][Full Text] [Related]
28. Intracellularly Degradable, Self-Assembled Amphiphilic Block Copolycurcumin Nanoparticles for Efficient In Vivo Cancer Chemotherapy. Lv L; Guo Y; Shen Y; Liu J; Zhang W; Zhou D; Guo S Adv Healthc Mater; 2015 Jul; 4(10):1496-501, 1423. PubMed ID: 26033838 [TBL] [Abstract][Full Text] [Related]
29. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration. Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149 [TBL] [Abstract][Full Text] [Related]
30. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
31. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. Talelli M; Iman M; Varkouhi AK; Rijcken CJ; Schiffelers RM; Etrych T; Ulbrich K; van Nostrum CF; Lammers T; Storm G; Hennink WE Biomaterials; 2010 Oct; 31(30):7797-804. PubMed ID: 20673684 [TBL] [Abstract][Full Text] [Related]
32. pH-responsive polymer-drug conjugates as multifunctional micelles for cancer-drug delivery. Kang Y; Ha W; Liu YQ; Ma Y; Fan MM; Ding LS; Zhang S; Li BJ Nanotechnology; 2014 Aug; 25(33):335101. PubMed ID: 25073730 [TBL] [Abstract][Full Text] [Related]
33. Galactose-Containing Polymer-DOX Conjugates for Targeting Drug Delivery. Sun Y; Zhang J; Han J; Tian B; Shi Y; Ding Y; Wang L; Han J AAPS PharmSciTech; 2017 Apr; 18(3):749-758. PubMed ID: 27287244 [TBL] [Abstract][Full Text] [Related]
34. Dual pH-sensitive liposomes with low pH-triggered sheddable PEG for enhanced tumor-targeted drug delivery. Kanamala M; Palmer BD; Jamieson SM; Wilson WR; Wu Z Nanomedicine (Lond); 2019 Aug; 14(15):1971-1989. PubMed ID: 31355712 [No Abstract] [Full Text] [Related]
35. HPMA copolymer-cyclic RGD conjugates for tumor targeting. Pike DB; Ghandehari H Adv Drug Deliv Rev; 2010 Feb; 62(2):167-83. PubMed ID: 19951733 [TBL] [Abstract][Full Text] [Related]
36. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio. Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630 [TBL] [Abstract][Full Text] [Related]
38. Multifunctional hollow nanoparticles based on graft-diblock copolymers for doxorubicin delivery. Lu PL; Chen YC; Ou TW; Chen HH; Tsai HC; Wen CJ; Lo CL; Wey SP; Lin KJ; Yen TC; Hsiue GH Biomaterials; 2011 Mar; 32(8):2213-21. PubMed ID: 21176954 [TBL] [Abstract][Full Text] [Related]
39. Doxorubicin conjugate of poly(ethylene glycol)-block-polyphosphoester for cancer therapy. Sun CY; Dou S; Du JZ; Yang XZ; Li YP; Wang J Adv Healthc Mater; 2014 Feb; 3(2):261-72. PubMed ID: 23852934 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and characterization of pH-sensitive poly(itaconic acid)-poly(ethylene glycol)-folate-poly(l-histidine) micelles for enhancing tumor therapy and tunable drug release. Sun Y; Li Y; Nan S; Zhang L; Huang H; Wang J J Colloid Interface Sci; 2015 Nov; 458():119-29. PubMed ID: 26210102 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]